Peer-influenced content. Sources you trust. No registration required. This is HCN.
Therapeutic Advances in Musculoskeletal Disease
Early treatment phases may transiently promote immune activation, whereas sustained therapy, by reducing BMI and lowering systemic inflammation, may mitigate this effect.
Cardiology March 13th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Despite its reputation as a malabsorptive disorder, 27% of celiac disease patients in the United States are overweight, highlighting the importance of maintaining clinical suspicion regardless of body habitus.
Endocrinology, Diabetes, Metabolism January 8th 2025
Salt-and-pepper skin pigmentation can be an early indicator of systemic sclerosis, characterized by vitiligo-like depigmentation with sparing of perifollicular areas.
Allergy & Immunology October 14th 2024
Northwestern Medicine
Researchers have identified insufficient activation of the aryl hydrocarbon receptor (AHR) pathway as a key driver in lupus pathogenesis, offering a new target for therapeutic intervention.
Allergy & Immunology July 17th 2024
Epoch Health
Hashimoto’s Thyroiditis is linked to a complex array of symptoms ranging from thyroid enlargement and systemic metabolic disruptions to severe fatigue and cognitive decline, highlighting the need for comprehensive diagnostic strategies and personalized treatment plans.
Endocrinology, Diabetes, Metabolism May 17th 2024
Annals of Internal Medicine
In a recent study, color Doppler ultrasound identified Giant Cell Arteritis in 44% of suspected cases, proving its effectiveness as a first-line diagnostic tool. This method offers a significant advantage in managing patient care by potentially reducing the need for subsequent invasive testing.
Geriatrics May 15th 2024